Retrospective Analysis of 37,287 Observation Years after Peripheral Blood Stem Cell Donation

This publication has 19 references indexed in Scilit:

• A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies
  Bone Marrow Transplantation, 2015
• Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation
  Blood, 2014
• Allogeneic hematopoietic stem cell donation—standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)
  Bone Marrow Transplantation, 2012
• Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations
  Bone Marrow Transplantation, 2010
• Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors
  Blood, 2009
• The use of granulocyte–colony‐stimulating factor in volunteer unrelated hemopoietic stem cell donors
  Transfusion, 2008
• Long‐term safety of filgrastim (rhG‐CSF) administration
  British Journal of Haematology, 2007
• Possible harmful effects of short course granulocyte colony‐stimulating factor in normal donors
  British Journal of Haematology, 2006
• Evaluation of Hematopoietic Stem Cell Donors
  Hematology-American Society Hematology Education Program, 2005
• Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells
  Experimental Hematology, 2004